Denise Laronde

Dr. Denise Laronde

University of British Columbia
+1
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Cancer Prevention Research
Verified
Journal Article
Open access
PDF file
LZLewei Zhang
Lewei Zhang
CPCatherine F. Poh
Catherine F. Poh
MWMichele Williams
Michele Williams
DLDenise Laronde
Denise Laronde
KBKen Berean
Ken Berean
MRMiriam P. Rosin
Miriam P. Rosin
A major barrier to oral cancer prevention has been the lack of validated risk predictors for oral premalignant lesions (OPL). In 2000, we proposed a loss of heterozygosity (LOH) risk model in a retrospective study. This paper validated the previously reported LOH profiles as risk predictors and developed refined models via the largest longitudinal study to date of low-grade OPLs from a population-based patient group. Analysis involved a prospective cohort of 296 patients with primary mild/moderate oral dysplasia enrolled in the Oral Cancer Prediction Longitudinal Study. LOH status was determined in these OPLs. Patients were classified into high-risk or low-risk profiles to validate the 2000 model. Risk models were refined using recursive partitioning and Cox regression analyses. The prospective cohort validated that the high-risk lesions (3p and/or 9p LOH) had a 22.6-fold increase in risk (P = 0.002) compared with low-risk lesions (3p and 9p retention). Addition of another 2 markers (loci on 4q/17p) further improved the risk prediction, with five-year progression rates of 3.1%, 16.3%, and 63.1% for the low-, intermediate-, and high-risk lesions, respectively. Compared with the low-risk group, intermediate- and high-risk groups had 11.6-fold and 52.1-fold increase in risk (P < 0.001). LOH profiles as risk predictors in the refined model were validated in the retrospective cohort. Multicovariate analysis with clinical features showed LOH models to be the most significant predictors of progression. LOH profiles can reliably differentiate progression risk for OPLs. Potential uses include increasing surveillance for patients with elevated risk, improving target intervention for high-risk patients while sparing a large number of low-risk patients from needless screening and treatment. Cancer Prev Res; 5(9); 1081–9. ©2012 AACR.

18 September 2006 in Head & Neck
Verified
Journal Article
Closed access
PDF file
CPCatherine F. Poh
Catherine F. Poh
SNSamson P. Ng
Samson P. Ng
PWP. Michele Williams
P. Michele Williams
LZLewei Zhang
Lewei Zhang
DLDenise Laronde
Denise Laronde
MRMiriam P. Rosin
Miriam P. Rosin

10 June 2013 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
PDF file
DLDenise Laronde
Denise Laronde
PWP. M. Williams
P. M. Williams
THT. G. Hislop
T. G. Hislop
CPCatherine Poh
Catherine Poh
SNSamson Ng
Samson Ng
MRMiriam P. Rosin
Miriam P. Rosin

22 July 2011 in Periodontology 2000
Verified
Journal Article
Closed access
PDF file
CPCatherine F. Poh
Catherine F. Poh
CMCalum MacAulay
Calum MacAulay
DLDenise Laronde
Denise Laronde
PWP. Michele Williams
P. Michele Williams
LZLewei Zhang
Lewei Zhang
MRMiriam P. Rosin
Miriam P. Rosin

1 September 2016 in Oral Oncology
Verified
Journal Article
Closed access
LZLewei Zhang
Lewei Zhang
TLTarinee Lubpairee
Tarinee Lubpairee
DLDenise Laronde
Denise Laronde
MRMiriam P. Rosin
Miriam P. Rosin

25 January 2014 in Community Dentistry and Oral Epidemiology
Verified
Journal Article
Closed access
PDF file
DLDenise Laronde
Denise Laronde
PWP. M. Williams
P. M. Williams
THT. G. Hislop
T. G. Hislop
CPCatherine Poh
Catherine Poh
SNSamson Ng
Samson Ng
MRMiriam P. Rosin
Miriam P. Rosin